Hosted on MSN17h
Improved lipid-polymer nanoparticle could advance inhalable mRNA medications and vaccines
Most people don't enjoy getting shots for treatments or vaccines ... oRNA Therapeutics and Moderna, biotechnology companies ...
No More Needles? Inhalable mRNA Could Revolutionize Medicine
A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...
EurekAlert!1d
An advance toward inhalable mRNA medications, vaccines
Most people don’t enjoy getting shots for treatments or vaccines. So ... Chemical Society reports steps toward making inhalable mRNA medicines a possibility. Researchers outline their improved ...
Inside Moderna’s Tech-Driven Culture: Insights From CIO Brad Miller
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
Pharmabiz3d
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...
Joplin Globe6d
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
The vaccine uses the same lipid nanoparticles (LNPs) as the Moderna COVID-19 vaccine. About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA ...
Moderna Q3 Revenue Beats On Updated COVID-19 Vaccine, Slashes Expenses For 2024
On Thursday, Moderna Inc (NASDAQ:MRNA) stock is trading higher after the company reported better-than-expected third-quarter ...